CorMedix Inc. (CRMD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for CorMedix Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 5.14x | -26.60x | -4.13x | -5.70x | -6.07x | -9.63x |
| P/B Ratio | 2.07x | 5.63x | 2.73x | 3.08x | 2.73x | 4.80x |
| P/S Ratio | 2.69x | 10.97x | 0.00x | 2589.59x | 896.33x | 887.07x |
| Profitability | ||||||
| Gross Margin | 88.5% | 92.7% | 0.0% | 94.3% | 22.0% | 14.4% |
| Operating Margin | 48.2% | -51.4% | 0.0% | -46819.9% | -15417.5% | -11378.4% |
| Net Margin | 52.3% | -41.2% | 0.0% | -45409.9% | -14774.7% | -9207.7% |
| EBITDA Margin | 53.0% | -43.7% | 0.0% | -45945.1% | -15385.1% | -11294.7% |
| Liquidity | ||||||
| Current Ratio | 2.01x | 3.39x | 6.97x | 9.44x | 12.44x | 11.58x |
| Quick Ratio | 1.84x | 3.16x | 6.78x | 9.44x | 12.43x | 11.54x |
| Leverage | ||||||
| Debt/Equity | 0.37x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x |
YoY = year-over-year change. Source: FMP..